| Product Code: ETC12652015 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Leishmaniasis Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Leishmaniasis Market - Industry Life Cycle |
3.4 Israel Leishmaniasis Market - Porter's Five Forces |
3.5 Israel Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Israel Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 Israel Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Israel Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 Israel Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of leishmaniasis cases in Israel |
4.2.2 Growing awareness about the disease among healthcare professionals and the general population |
4.2.3 Government initiatives to control the spread of leishmaniasis in Israel |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatment options for leishmaniasis in Israel |
4.3.2 High treatment costs associated with managing leishmaniasis cases |
4.3.3 Lack of skilled healthcare professionals specialized in treating leishmaniasis |
5 Israel Leishmaniasis Market Trends |
6 Israel Leishmaniasis Market, By Types |
6.1 Israel Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 Israel Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 Israel Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 Israel Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 Israel Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 Israel Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 Israel Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 Israel Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 Israel Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 Israel Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 Israel Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 Israel Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 Israel Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 Israel Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 Israel Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 Israel Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 Israel Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 Israel Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Israel Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 Israel Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 Israel Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 Israel Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 Israel Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 Israel Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 Israel Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 Israel Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 Israel Leishmaniasis Market Import-Export Trade Statistics |
7.1 Israel Leishmaniasis Market Export to Major Countries |
7.2 Israel Leishmaniasis Market Imports from Major Countries |
8 Israel Leishmaniasis Market Key Performance Indicators |
8.1 Number of reported leishmaniasis cases in Israel |
8.2 Adoption rate of new treatment protocols for leishmaniasis |
8.3 Funding allocation towards leishmaniasis research and control programs |
9 Israel Leishmaniasis Market - Opportunity Assessment |
9.1 Israel Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Israel Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 Israel Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Israel Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 Israel Leishmaniasis Market - Competitive Landscape |
10.1 Israel Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 Israel Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here